← Back to Search

Behavioral Intervention

Wait-list control arm for Schizophrenia (MIND Trial)

N/A
Waitlist Available
Led By Chinyu Wu, PhD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of SMI
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1, 10, and 20
Awards & highlights

MIND Trial Summary

This trial aims to see if a diabetes lifestyle program called Lifestyle MIND can help people with serious mental illness control their diabetes. They will compare the outcomes of participants in the program with those who are not

Who is the study for?
This trial is for individuals with serious mental illness (SMI) such as schizophrenia, bipolar disorder, or depression who also have Type 2 Diabetes. Participants should be interested in a diabetes lifestyle program called Lifestyle MIND and willing to be randomly assigned to start the program at different times.Check my eligibility
What is being tested?
The study tests the effectiveness of Lifestyle MIND, a diabetes lifestyle intervention designed for people with SMI. It compares blood sugar control, self-management of diabetes, physical activity levels, emergency visits, psychiatric hospitalizations, and overall well-being between two groups: one receiving the intervention immediately and another on a wait-list.See study design
What are the potential side effects?
Since Lifestyle MIND is a lifestyle intervention rather than medication-based treatment, typical drug side effects are not expected. However, changes in diet and exercise may cause discomfort or require adjustment periods.

MIND Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a serious mental illness.

MIND Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1, 10, and 20
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 1, 10, and 20 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1c (HbA1c)
Hours of Active and Sedentary Behavior
Number of emergency department (ED) visits and psychiatric hospitalizations
+2 more

MIND Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait-list control armExperimental Treatment1 Intervention
Delayed Lifestyle MIND
Group II: Intervention ArmExperimental Treatment1 Intervention
Lifestyle MIND

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
453 Previous Clinical Trials
91,941 Total Patients Enrolled
11 Trials studying Schizophrenia
1,101 Patients Enrolled for Schizophrenia
Chinyu Wu, PhDPrincipal InvestigatorThe University of Texas Health Science Center at San Antonio
1 Previous Clinical Trials
1 Trials studying Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age criterion for participants in this medical study limited to individuals below 50 years old?

"Eligible participants for this research endeavor must fall within the age bracket of 18 to 65 years. It is noteworthy that there are a total of 217 clinical trials focusing on individuals under 18, and 1469 trials cater specifically to those aged over 65."

Answered by AI

Is this research study currently accepting new participants?

"The clinical trial listed on clinicaltrials.gov is not in the recruitment phase. It was first published on June 1, 2024, with the most recent update made on April 22, 2024. Despite this specific trial being closed for enrollment currently, there are approximately 1956 other trials actively seeking participants."

Answered by AI
~13 spots leftby Apr 2025